Showing 141 - 160 results of 66,489 for search '(( e non decrease ) OR ((( 5 nn decrease ) OR ( 5 ((nmon decrease) OR (a decrease)) ))))', query time: 0.87s Refine Results
  1. 141
  2. 142

    Subgroup analyses of the association between decreases in serum UA levels and poor functional outcome at 3 months. by Kuniyuki Nakamura (13040299)

    Published 2023
    “…<p>The ORs and 95% CIs of poor functional outcome (defined as an mRS score of 3–6 at 3 months) are shown according to UA decrease rate grade (G1 to G4) in each subgroup. The subgroups included (<b>A</b>) age (<75 or ≥75 years), (<b>B</b>) sex (women or men), (<b>C</b>) stroke subtype (non-cardioembolic or cardioembolic), (<b>D</b>) neurological severity (NIHSS <5 or ≥5), (<b>E</b>) CKD (presence or absence), and (<b>F</b>) UA level on admission (<292 or ≥292 μmol/L for women, <351 or ≥351 μmol/L for men). …”
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148
  9. 149

    Time course of the variances (<i>V</i><sub><i>ip</i></sub>, <i>V</i><sub><i>g</i></sub>) after switching interaction strength. by Naoto Nishiura (11668953)

    Published 2021
    “…The two variances of the non-target output genes decrease, while <i>V</i><sub><i>g</i></sub> < <i>V</i><sub><i>ip</i></sub> is maintained throughout the evolutionary course (a). …”
  10. 150
  11. 151
  12. 152

    Data_Sheet_1_rdHSV-CA8 non-opioid analgesic gene therapy decreases somatosensory neuronal excitability by activating Kv7 voltage-gated potassium channels.docx by Munal B. Kandel (18526539)

    Published 2024
    “…This study tested the hypothesis that novel JDNI8 replication-defective herpes simplex-1 viral vectors (rdHSV) carrying a CA8 transgene (vHCA8) reduce primary afferent neuronal excitability. …”
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157
  18. 158
  19. 159
  20. 160